Table of Content



Chapter 1 Research Objective
1.1 Objective - 1
1.2 Objective - 2
1.3 Objective - 3
1.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.3 Competitive Insights
2.4 Hyaluronic Acid Market Snapshot
Chapter 3 Hyaluronic Acid Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market influencer analysis
3.4 Penetration and Growth Prospect Mapping
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increasing geriatric population and prevalence of osteoarthritis
3.5.1.2 Growing demand for antiaging solutions and minimally invasive aesthetic treatments
3.5.1.3 Growing application in regenerative medicine and tissue engineering
3.5.1.4 Market approval and launch of new products
3.5.2 Market restraint analysis
3.5.2.1 High cost and side effects associated with hyaluronic acid cycles
3.6 Business Environment Analysis Tools
3.6.1 Industry analysis - Porter’s
3.6.1.1 Competitive rivalry
3.6.1.2 Threat of new entrants
3.6.1.3 Bargaining power of buyers
3.6.1.4 Bargaining power of suppliers
3.6.1.5 Threat of substitutes
3.6.2 PESTEL analysis
3.6.2.1 Political landscape
3.6.2.2 Economic and social landscape
3.6.2.3 Technology landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Joint ventures
3.7.2 Mergers & acquisitions
Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 Hyaluronic Acid Market: Application Movement Analysis, USD Million, 2019 & 2027
4.2.1 Dermal fillers
4.2.1.1 Dermal fillers market, 2016 - 2027 (USD Million)
4.2.2 Osteoarthritis
4.2.2.1 Osteoarthritis market, 2016 - 2027 (USD Million)
4.2.2.1.1 Single injection
4.2.2.1.1.1 Single injection market, 2016 - 2027 (USD Million)
4.2.2.1.2 Three injection
4.2.2.1.2.1 Three injection market, 2016 - 2027 (USD Million)
4.2.2.1.3 Five injection
4.2.2.1.3.1 Five injection market, 2016 - 2027 (USD Million)
4.2.3 Ophthalmic
4.2.3.1 Ophthalmic market, 2016 - 2027 (USD Million)
4.2.4 Vesicoureteral reflux
4.2.4.1 Vesicoureteral market, 2016 - 2027 (USD Million)
Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis, By Application
5.1 Regional Market Share Analysis, 2019 & 2027
5.2 Regional Market Dashboard
5.3 Regional Market Snapshot (Countries)
5.4 North America
5.4.1 North America hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.4.2 U.S.
5.4.2.1 U.S. hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.4.3 Canada
5.4.3.1 Canada hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5 Europe
5.5.1 Europe hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5.2 Germany
5.5.2.1 Germany hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5.3 U.K.
5.5.3.1 U.K. hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5.4 France
5.5.4.1 France hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5.5 Italy
5.5.5.1 Italy hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.5.6 Spain
5.5.6.1 Spain hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.6 Asia Pacific
5.6.1 Asia Pacific hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.6.2 Japan
5.6.2.1 Japan hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.6.3 China
5.6.3.1 China hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.6.4 India
5.6.4.1 India hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.7 Latin America
5.7.1 Latin America hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.7.2 Brazil
5.7.2.1 Brazil hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.7.3 Mexico
5.7.3.1 Mexico hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.8 Middle East & Africa
5.8.1 Middle East & Africa hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
5.8.2 South Africa
5.8.2.1 South Africa hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 6 Reimbursement Outlook
6.1 Reimbursement By Product
6.1.1 Gel-one
6.1.2 EUFLEXXA
6.1.3 Synvisc-One
6.1.4 Supartz
6.1.5 Hyalgan
6.1.6 Monovisc
6.1.7 Orthovisc
6.1.8 Others
6.2 Reimbursement By Region
6.2.1 Canada
6.2.2 China
6.2.3 Japan
6.2.4 India
6.2.5 Brazil
6.2.6 South Africa
6.2.7 Europe
6.2.7.1 U.K.
6.2.7.2 Germany
6.2.7.3 France
6.2.7.4 Italy
6.2.7.5 Spain
Chapter 7 Competitive Landscape
7.1 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.2 Vendor Landscape
7.2.1 List of key distributors and channel partners
7.2.2 Strategy mapping
7.2.2.1 Partnerships
7.2.2.2 Launch of new products
7.2.2.3 Merger & acquisition
7.2.2.4 Geographical expansion
7.2.2.5 Marketing & promotions
7.2.3 Company market position analysis (market presence, geographic presence, product portfolio, startegic initiatves)
7.3 Company Profiles
7.3.1 Allergan
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.1.5 SWOT analysis
7.3.1.6 Strategic initiatives
7.3.2 Sanofi
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3.5 SWOT analysis
7.3.4.6 Strategic initiatives
7.3.3 Genzyme Corporation
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.3.5 SWOT analysis
7.3.3.6 Strategic initiatives
7.3.4 Salix Pharmaceuticals, Inc.
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.4.5 SWOT analysis
7.3.4.6 Strategic initiatives
7.3.5 Seikagaku Corporation
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.5.5 SWOT analysis
7.3.5.6 Strategic initiatives
7.3.6 F. Hoffmann-La Roche AG
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.6.5 SWOT analysis
7.3.6.6 Strategic initiatives
7.3.7 Galderma S.A.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.7.5 SWOT analysis
7.3.7.6 Strategic initiatives
7.3.8 Zimmer Biomet
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.8.5 SWOT analysis
7.3.8.6 Strategic initiatives
7.3.9 Smith & Nephew Plc
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.9.5 SWOT analysis
7.3.9.6 Strategic initiatives
7.3.10 Ferring B.V.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.10.5 SWOT analysis
7.3.10.6 Strategic initiatives
7.3.11 Lifecore Biomedical, LLC
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.11.5 SWOT analysis
7.4.11.6 Strategic initiatives
7.3.12 HTL Biotechnology
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.4.12.5 SWOT analysis
7.4.12.6 Strategic initiatives
7.3.13 Shiseido Company, Limited
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.4.13.3 Product benchmarking
7.4.13.4 Strategic initiatives
7.4.13.5 SWOT analysis
7.4.13.6 Strategic initiatives
7.3.14 Bloomage Freda Biopharm Co. Ltd.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.4.14.3 Product benchmarking
7.4.14.4 Strategic initiatives
7.4.14.5 SWOT analysis
7.4.14.6 Strategic initiatives
7.3.15 LG Life Sciences Ltd
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.4.15.3 Product benchmarking
7.4.15.4 Strategic initiatives
7.4.15.5 SWOT analysis
7.4.15.6 Strategic initiatives
7.3.16 Maruha Nichiro, Inc.
7.3.16.1 Company overview
7.3.16.2 Financial performance
7.4.16.3 Product benchmarking
7.4.16.4 Strategic initiatives
7.4.16.5 SWOT analysis
7.4.16.6 Strategic initiatives
Chapter 8 Recommendations
Chapter 9 Research Methodology & Scope
9.1 Research Methodology
9.1.1 Information procurement
9.1.1.1 Purchased database:
9.1.1.2 GVR’s internal database
9.1.2 Primary research:
9.2 Research Scope And Assumptions
9.3 List To Data Sources
Chapter 10 Report FAQs
10.1 How Do I Trust Your Report Quality/Data Accuracy?
10.2 My Research Requirement Is Very Specific; Can I Customize This Report?
10.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
10.4 How Do You Arrive At These Market Numbers?
10.5 Who Are Your Clients?
10.6 How Will I Receive This Report?
Chapter 11 Appendix
Chapter 12 Compass - Cloud Based Report Delivery Platform
Chapter 13 Related Reports



List of Tables



TABLE 1 North America hyaluronic acid market, by country, 2016 - 2027 (USD Million)
TABLE 2 North America hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 3 U.S. hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 4 Canada hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 5 Europe hyaluronic acid market, by country, 2016 - 2027 (USD Million)
TABLE 6 Europe hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 7 U.K. hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 8 Germany hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 9 France hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 10 Italy hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 11 Spain hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 12 Asia Pacific hyaluronic acid market, by country, 2016 - 2027 (USD Million)
TABLE 13 Asia Pacific hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 14 Japan hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 15 China hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 16 India hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 17 Latin America hyaluronic acid market, by country, 2016 - 2027 (USD Million)
TABLE 18 Latin America hyaluronic acid market by application, 2016 - 2027 (USD MILLION)
TABLE 19 Brazil hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 20 Mexico hyaluronic acid market by application, 2016 - 2027 (USD Million)
TABLE 21 MEA hyaluronic acid market, by country, 2016 - 2027 (USD Million)
TABLE 22 MEA hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 23 South Africa hyaluronic acid market, by application, 2016 - 2027 (USD Million)
TABLE 24 List of secondary sources
TABLE 25 List of abbreviation